Pay Your Bill Online Test Menu Test Results Online LabCare Plus Results

BRCA Inherited Cancer Screen

Counsyl’s BRCA test screens for genetic mutations of BRCA1 and BRCA2 to identify those patients, women and men, at risk for breast, ovarian and prostate cancers.  According to the National Cancer Institute, the screening for BRCA1 and BRCA2 can identify those patients at increased risk for fallopian tube and peritoneal cancer, and to a lesser extent, pancreatic cancer.

BRCA testing from Counsyl screens for known gene variants (Examples:  BRCA1 and 2; Ashkenazi variant) and uncommon gene variants through both gene sequencing and deletion/duplication testing, offering a sensitivity and specificity of greater than 99.99%.  Uncommon disease variants detected will be reported as they may become more important once technology has identified the role of these variants as disease or non-disease causing.  Complimentary counseling is provided by board-certified genetic counselors via telephone and consult notes will be provided to the physician as a follow-up to the patient’s discussion with the counselor.

To learn more about the Inherited Cancer Screen, please visit the Counsyl Website. Please contact your Shiel Medical Laboratory representative to learn more about Counsyl’s BRCA Inherited Cancer Screen for BRCA1 and BRCA2, guidelines for whom you should test, specimen requirements and any billing questions you may have.